Crucell Announces Record Revenues and Profits for Full Year 2009 - MarketWatch
Crucell Announces Record Revenues and Profits for Full Year 2009 - MarketWatch - Crucell Announces Record Revenues and Profits for Full Year 2009MarketWatchTuberculosis Vaccine(Phase II): Development of the candidate vaccine AERAS-402/Crucell Ad35 is being carried out in collaboration with the Aeras Global TB ...and more » [Google TB NEWS]
- bob's blog
- Login or register to post comments


